2013 American Transplant Congress
Single Center Evaluation of Intravenous Immunoglobulin in Renal Transplantation, A
Purpose. Renal transplant candidates with high levels of anti-HLA antibodies have longer wait times on the deceased donor list and overall lower transplant rates compared…2013 American Transplant Congress
Long-Range, CIS-Regulatory Architecture of the IL-2 and IL-21 Multi-Locus Region
IL-2 is a crucial cytokine with roles in both immunity and tolerance, and IL-21 mediates inflammation by promoting B cell and CTL differentiation. These cytokines…2013 American Transplant Congress
Irradiation and T Cell Depletion Augment Bone Marrow-Derived Chimerism at the Cost of Morbidity and Mortality in a Non-Human Primate Model of Vascularized Composite Allotransplantation
PurposeWe have shown that vascularized bone marrow (VBM) prolongs vascularized composite allograft survival in nonhuman primates (NHP). To explore the potential for chimerism and tolerance,…2013 American Transplant Congress
Renal Allograft Tolerance Can Be Achieved in Non-Human Primates Via Delayed Mixed-Hematopoietic Chimerism and Alefacept Treatment
Renal allograft tolerance has been achieved in MHC-mismatched NHPs and patients via the mixed-chimerism approach. Activation/expansion of donor-reactive CD8+ effector memory T cells (TEMs) represents…2013 American Transplant Congress
Single Donor-Derived Strongyloides in Solid Organ Transplants
Geisinger Medical Center, Danville; Temple University Hospital, Philadelphia
CDC was notified of Strongyloides infection in transplant recipients of kidneys, pancreas and heart from same deceased donor. Concern for donor-derived strongyloidiasis prompted an investigation…2013 American Transplant Congress
Ciprofloxacin Combined with SMZ/TMP Prophylaxis Reduces the Incidence of UTIs Following Kidney Transplantation
UCSF, San Francisco; UCSF, San Francisco
Introduction:Urinary tract infections (UTIs) are major causes of morbidity and recurrent hospitalizations following kidney transplantation. To date there are no guidelines on antibiotic prophylaxis for…2013 American Transplant Congress
Antiviral Prophylaxis for HBsAg-Positive Renal Transplant Recipients Treated with Rituximab®
The risk of Hepatitis B virus (HBV) reactivation under immunosuppressant has been well known. Especially, rituximab® is identified as strong risk factors of HBV reactivation…2013 American Transplant Congress
Treatment Option in Diabetic End Stage Renal Disease Patients with Potential Living Kidney Donor: PAK vs. SPLK
In diabetic patients with end stage renal disease who has a potential living kidney donor, pancreas after living kidney transplantation (PAK) or simultaneous cadaveric pancreas…2013 American Transplant Congress
Role of Cardiac Rehabilitation after Heart Transplantation in the Reduction of Cardiac Allograft Vasculopathy, The
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: Cardiac rehabilitation after heart transplantation has been documented to be beneficial for increased physical activity via a randomized trial using cardiopulmonary stress testing. It…2013 American Transplant Congress
Impact of HLA-DQ Matching on Alloantibody Production in Primary Renal Transplant Recipients, The
Recent findings have shown the DQ donor specific alloantibodies (DSA) are associated with transplant glomerulopathy and seem to appear more often than other loci DSA.…
American Transplant Congress abstracts